-
Something wrong with this record ?
Group I PAK inhibitor IPA-3 induces cell death and affects cell adhesivity to fibronectin in human hematopoietic cells
K. Kuželová, D. Grebeňová, A. Holoubek, P. Röselová, A. Obr,
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
Directory of Open Access Journals
from 2006
Free Medical Journals
from 2006
Public Library of Science (PLoS)
from 2006
PubMed Central
from 2006
Europe PubMed Central
from 2006
ProQuest Central
from 2006-12-01
Open Access Digital Library
from 2006-01-01
Open Access Digital Library
from 2006-10-01
Open Access Digital Library
from 2006-01-01
Medline Complete (EBSCOhost)
from 2008-01-01
Nursing & Allied Health Database (ProQuest)
from 2006-12-01
Health & Medicine (ProQuest)
from 2006-12-01
Public Health Database (ProQuest)
from 2006-12-01
ROAD: Directory of Open Access Scholarly Resources
from 2006
- MeSH
- Apoptosis drug effects MeSH
- Cell Adhesion drug effects MeSH
- Disulfides metabolism pharmacology MeSH
- Actin Depolymerizing Factors chemistry metabolism MeSH
- Fibronectins metabolism MeSH
- Phosphorylation drug effects MeSH
- Hematopoiesis drug effects MeSH
- Protein Kinase Inhibitors metabolism pharmacology MeSH
- Intracellular Space drug effects metabolism MeSH
- Blood Cells cytology drug effects MeSH
- Leukemia pathology MeSH
- Humans MeSH
- Lymphoma pathology MeSH
- RNA, Small Interfering genetics MeSH
- Naphthols metabolism pharmacology MeSH
- p21-Activated Kinases antagonists & inhibitors deficiency genetics MeSH
- Cell Proliferation drug effects MeSH
- Gene Expression Regulation drug effects MeSH
- Serine metabolism MeSH
- Gene Silencing MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
P21-activated kinases (PAKs) are involved in the regulation of multiple processes including cell proliferation, adhesion and migration. However, the current knowledge about their function is mainly based on results obtained in adherent cell types. We investigated the effect of group I PAK inhibition using the compound IPA-3 in a variety of human leukemic cell lines (JURL-MK1, MOLM-7, K562, CML-T1, HL-60, Karpas-299, Jurkat, HEL) as well as in primary blood cells. IPA-3 induced cell death with EC50 ranging from 5 to more than 20 μM. Similar range was found for IPA-3-mediated dephosphorylation of a known PAK downstream effector, cofilin. The cell death was associated with caspase-3 activation, PARP cleavage and apoptotic DNA fragmentation. In parallel, 20 μM IPA-3 treatment induced rapid and marked decrease of the cell adhesivity to fibronectin. Per contra, partial reduction of PAK activity using lower dose IPA-3 or siRNA resulted in a slight increase in the cell adhesivity. The changes in the cell adhesivity were also studied using real-time microimpedance measurement and by interference reflection microscopy. Significant differences in the intracellular IPA-3 level among various cell lines were observed indicating that an active mechanism is involved in IPA-3 transport.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15014452
- 003
- CZ-PrNML
- 005
- 20150421092158.0
- 007
- ta
- 008
- 150420s2014 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1371/journal.pone.0092560 $2 doi
- 035 __
- $a (PubMed)24664099
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Kuželová, Kateřina $u Department of Cellular Biochemistry, Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
- 245 10
- $a Group I PAK inhibitor IPA-3 induces cell death and affects cell adhesivity to fibronectin in human hematopoietic cells / $c K. Kuželová, D. Grebeňová, A. Holoubek, P. Röselová, A. Obr,
- 520 9_
- $a P21-activated kinases (PAKs) are involved in the regulation of multiple processes including cell proliferation, adhesion and migration. However, the current knowledge about their function is mainly based on results obtained in adherent cell types. We investigated the effect of group I PAK inhibition using the compound IPA-3 in a variety of human leukemic cell lines (JURL-MK1, MOLM-7, K562, CML-T1, HL-60, Karpas-299, Jurkat, HEL) as well as in primary blood cells. IPA-3 induced cell death with EC50 ranging from 5 to more than 20 μM. Similar range was found for IPA-3-mediated dephosphorylation of a known PAK downstream effector, cofilin. The cell death was associated with caspase-3 activation, PARP cleavage and apoptotic DNA fragmentation. In parallel, 20 μM IPA-3 treatment induced rapid and marked decrease of the cell adhesivity to fibronectin. Per contra, partial reduction of PAK activity using lower dose IPA-3 or siRNA resulted in a slight increase in the cell adhesivity. The changes in the cell adhesivity were also studied using real-time microimpedance measurement and by interference reflection microscopy. Significant differences in the intracellular IPA-3 level among various cell lines were observed indicating that an active mechanism is involved in IPA-3 transport.
- 650 _2
- $a faktory depolymerizující aktin $x chemie $x metabolismus $7 D051339
- 650 _2
- $a apoptóza $x účinky léků $7 D017209
- 650 _2
- $a krevní buňky $x cytologie $x účinky léků $7 D001773
- 650 _2
- $a buněčná adheze $x účinky léků $7 D002448
- 650 _2
- $a proliferace buněk $x účinky léků $7 D049109
- 650 _2
- $a disulfidy $x metabolismus $x farmakologie $7 D004220
- 650 _2
- $a fibronektiny $x metabolismus $7 D005353
- 650 _2
- $a regulace genové exprese $x účinky léků $7 D005786
- 650 _2
- $a umlčování genů $7 D020868
- 650 _2
- $a hematopoéza $x účinky léků $7 D006410
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a intracelulární prostor $x účinky léků $x metabolismus $7 D042541
- 650 _2
- $a leukemie $x patologie $7 D007938
- 650 _2
- $a lymfom $x patologie $7 D008223
- 650 _2
- $a naftoly $x metabolismus $x farmakologie $7 D009284
- 650 _2
- $a fosforylace $x účinky léků $7 D010766
- 650 _2
- $a inhibitory proteinkinas $x metabolismus $x farmakologie $7 D047428
- 650 _2
- $a malá interferující RNA $x genetika $7 D034741
- 650 _2
- $a serin $x metabolismus $7 D012694
- 650 _2
- $a p21 aktivované kinasy $x antagonisté a inhibitory $x nedostatek $x genetika $7 D054462
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Grebeňová, Dana $u Department of Cellular Biochemistry, Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
- 700 1_
- $a Holoubek, Aleš $u Department of Cellular Biochemistry, Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
- 700 1_
- $a Röselová, Pavla $u Department of Cellular Biochemistry, Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
- 700 1_
- $a Obr, Adam $u Department of Cellular Biochemistry, Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
- 773 0_
- $w MED00180950 $t PloS one $x 1932-6203 $g Roč. 9, č. 3 (2014), s. e92560
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/24664099 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20150420 $b ABA008
- 991 __
- $a 20150421092456 $b ABA008
- 999 __
- $a ok $b bmc $g 1072033 $s 897330
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 9 $c 3 $d e92560 $i 1932-6203 $m PLoS One $n PLoS One $x MED00180950
- LZP __
- $a Pubmed-20150420